Mundo is a Marie Curie Fellow at the University of Limerick and Professor Adjunct in Molecular Pathology at the University of Nairobi. His research is focussed on novel insights into the pathogenesis of virus-associated malignancies for the development of new therapies. His work received grant support totalling ~€1m. Mundo has contributed several important discoveries in the field: the first description of a non-canonical EBV-latency program in non-Hodgkin lymphoma (Abate et al. PLoS Pathogens, 2015); the first documented evidence of EBV in-situ in primary tumours classified as virus-negative (Mundo et al., Frontiers in Microbiology, 2017; Mundo et al, Modern Pathology, 2020).
Title : Modulation of MIR-663a expression by EBV-Encoded G Protein–coupled receptor (GPCR), BILF1, in burkitt lymphoma